BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17065421)

  • 1. Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology.
    Benlloch S; Payá A; Alenda C; Bessa X; Andreu M; Jover R; Castells A; Llor X; Aranda FI; Massutí B
    J Mol Diagn; 2006 Nov; 8(5):540-3. PubMed ID: 17065421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.
    Domingo E; Laiho P; Ollikainen M; Pinto M; Wang L; French AJ; Westra J; Frebourg T; Espín E; Armengol M; Hamelin R; Yamamoto H; Hofstra RM; Seruca R; Lindblom A; Peltomäki P; Thibodeau SN; Aaltonen LA; Schwartz S
    J Med Genet; 2004 Sep; 41(9):664-8. PubMed ID: 15342696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of DNA mismatch repair proteins expression and BRAF V600E mutation in a subset of early- and late-onset colorectal carcinoma patients in Mexico.
    Luévano-González A; Guzmán AQ; Ancer Rodríguez J; Ortiz López R; Rojas Martínez A; González Guerrero JF; Flores Gutiérrez JP
    Arch Med Res; 2011 Aug; 42(6):457-62. PubMed ID: 21945875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and application of the hot spot BRAF gene mutation (p.V600E) in the diagnostic strategy for Hereditary Nonpolyposis Colorectal Cancer.
    Kadiyska TK; Konstantinova DV; Atanasov VR; Kremensky IM; Mitev VI
    Cancer Detect Prev; 2007; 31(3):254-6. PubMed ID: 17566669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening.
    Bessa X; Ballesté B; Andreu M; Castells A; Bellosillo B; Balaguer F; Castellví-Bel S; Paya A; Jover R; Alenda C; Titó L; Martinez-Villacampa M; Vilella A; Xicola RM; Pons E; Llor X;
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):206-14. PubMed ID: 18096441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
    Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
    Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study.
    Wish TA; Hyde AJ; Parfrey PS; Green JS; Younghusband HB; Simms MI; Fontaine DG; Dicks EL; Stuckless SN; Gallinger S; McLaughlin JR; Woods MO; Green RC
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1831-9. PubMed ID: 20570909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency.
    Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG
    Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic BRAF-V600E mutations in familial colorectal cancer.
    Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF V600E mutation analysis simplifies the testing algorithm for Lynch syndrome.
    Jin M; Hampel H; Zhou X; Schunemann L; Yearsley M; Frankel WL
    Am J Clin Pathol; 2013 Aug; 140(2):177-83. PubMed ID: 23897252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E.
    Jarry A; Masson D; Cassagnau E; Parois S; Laboisse C; Denis MG
    Mol Cell Probes; 2004 Oct; 18(5):349-52. PubMed ID: 15294323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
    Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
    Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
    Matos P; Oliveira C; Velho S; Gonçalves V; da Costa LT; Moyer MP; Seruca R; Jordan P
    Gastroenterology; 2008 Sep; 135(3):899-906. PubMed ID: 18602919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF V600E Mutations in Endometrial Adenocarcinoma.
    He M; Breese V; Hang S; Zhang C; Xiong J; Jackson C
    Diagn Mol Pathol; 2013 Mar; 22(1):35-40. PubMed ID: 23370429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency.
    Oliveira C; Pinto M; Duval A; Brennetot C; Domingo E; Espín E; Armengol M; Yamamoto H; Hamelin R; Seruca R; Schwartz S
    Oncogene; 2003 Dec; 22(57):9192-6. PubMed ID: 14668801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia.
    Ewalt M; Nandula S; Phillips A; Alobeid B; Murty VV; Mansukhani MM; Bhagat G
    Hematol Oncol; 2012 Dec; 30(4):190-3. PubMed ID: 22246856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of BRAF V600E mutation by pyrosequencing.
    Tan YH; Liu Y; Eu KW; Ang PW; Li WQ; Salto-Tellez M; Iacopetta B; Soong R
    Pathology; 2008 Apr; 40(3):295-8. PubMed ID: 18428050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated PCR detection of BRAF mutations in colorectal adenocarcinoma: a diagnostic test accuracy study.
    Colling R; Wang LM; Soilleux E
    J Clin Pathol; 2016 May; 69(5):398-402. PubMed ID: 26537294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified Lynch syndrome screening algorithm in colon cancer: BRAF immunohistochemistry is efficacious and cost beneficial.
    Roth RM; Hampel H; Arnold CA; Yearsley MM; Marsh WL; Frankel WL
    Am J Clin Pathol; 2015 Mar; 143(3):336-43. PubMed ID: 25696791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF
    Grillo F; Paudice M; Pigozzi S; Dono M; Lastraioli S; Lugaresi M; Bozzano S; Tognoni C; Ali M; Sciallero S; Puccini A; Fassan M; Mastracci L
    Histopathology; 2024 Apr; 84(5):877-887. PubMed ID: 38173291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.